Personality disorder and drug use: A review

References

• O'Hare PA, Newcombe R, Matthews A, Buning E, Drucker E. The reduction of drug-related harm. Routledge, London 1992
   Google Scholar
• Cook CH. The Minnesota model in the management of drug and alcohol dependency: miracle, method or myth? Part I. The philosophy and the programme. Br J Addict 1988; 83: 625–634
   PubMedGoogle Scholar
• Craig RJ. Personality characteristics of heroin addicts: a review of the empirical literature with critique—Part II. Int J Addict 1979; 14: 607–626
   PubMed Web of Science ®Google Scholar
• Penk WE, Woodward WA, Robinowitz R, Parr WC. An MMPI comparison of polydrug and heroin abusers. J Abnorm Psychol 1980; 89: 299–302
   PubMed Web of Science ®Google Scholar
• Salmon R, Salmon S. The causes of heroin addiction—a review of the literature. Part I. Int J Addict 1977; 12: 679–696
   PubMed Web of Science ®Google Scholar
• Reich JH, Vasile RG. Effect of personality disorders on the treatment outcome of Axis I conditions: an update. J Nerv Mental Dis 1993; 181: 475–483
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders2nd edn. American Psychiatric Association, Washington 1968
   Google Scholar
• World Health Organization. The ICD-10 classification of mental and behavioural disorders. Clinical Descriptions and Diagnostic Guidelines. WHO, Geneva 1992
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders4th edn. American Psychiatric Association, Washington 1994
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders3rd edn. American Psychiatric Association, Washington 1980
   Google Scholar
• Hathaway SR, McKinley JC. The Minnesota Multi-phasic personality inventory manual. University of Minnesota Press, Minnesota 1951
   Google Scholar
• Klein DN. Depressive personality: reliability, validity and relation to dysthymia. J Abnorm Psychol 1990; 99: 412–421
   PubMed Web of Science ®Google Scholar
• Zimmerman M. Diagnosing personality disorders. A review of issues and research methods. Arch Gen Psychiatry 1994; 51: 225–245
   PubMed Web of Science ®Google Scholar
• Widiger TA, Frances A. Axis II personality disorders: diagnostic and treatment issues. Hosp Commun Psychiatry 1985; 42: 619–627
   Google Scholar
• Tyrer P, Casey P, Ferguson B. Personality disorder in perspective. Br J Psychiatry 1991; 159: 463–471
   PubMed Web of Science ®Google Scholar
• Tyrer P. Measurement of abnormal personality: a review. J Roy Soc Med 1987; 80: 637–639
   PubMed Web of Science ®Google Scholar
• Tyrer P, Seivewright H. Studies of outcome. Personality disorders: diagnosis, treatment and course, P Tyrer. Wright, London 1988, In
   Google Scholar
• Robins L, Price R. Adult disorders predicted by childhood conduct problems: results from the NIMH Epidemiologic Catchment Area Project. Psychiatry 1991; 54: 116–132
   PubMed Web of Science ®Google Scholar
• Moss HB, Tarter RE. Substance abuse, aggression and violence: what are the connections?. Am J Addict 1993; 2: 149–160
   Google Scholar
• Hammersley R, Forsyth A, Lavelle T. The criminality of new drug users in Glasgow. Br J Addict 1990; 85: 1583–1594
   PubMedGoogle Scholar
• Teichman M, Barnea Z, Ravav G. Personality and substance use among adolescents: a longitudinal study. Br J Addict 1989; 84: 181–190
   PubMedGoogle Scholar
• Soueif MI, Youssuf GS, Taha HS, et al. Use of psychoactive substances among male secondary school pupils in Egypt: a study on a nationwide representative sample. Drug Alcohol Depend 1990; 26: 63–79
   PubMed Web of Science ®Google Scholar
• Paris J. Personality disorders: a biopsychosocial model. J Pers Dis, 7: 255–264
   Web of Science ®Google Scholar
• Cloninger CR, Sigvardsson S, Bohman M. Predisposition to petty criminality in Swedish adoptees. II: cross-fostering analysis of gene-environment interaction. Arch Gen Psychiatry 1982; 39: 1242–1253
   PubMed Web of Science ®Google Scholar
• Torgesen S. Genetic factors in anxiety disorders. Arch Gen Psychiatry 1983; 37: 1272–1277
   Google Scholar
• McGuffin P, Thapar A. The genetics of personality disorder. Br J Psychiatry 1992; 160: 12–23
   PubMed Web of Science ®Google Scholar
• Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 1989; 46: 587–599
   PubMed Web of Science ®Google Scholar
• Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987; 44: 579–588
   Web of Science ®Google Scholar
• Siever LJ, Davis L. A psychobiological perspective on the personality disorders. Am J Psychiatry 1991; 148: 1647–1658
   PubMed Web of Science ®Google Scholar
• Loranger AW. Personality disorders examination (PDE) manual. DV Communications, Yonkers, NY 1988
   Google Scholar
• Loranger AW, Susman VL, Oldham JM, Russakoff LM. The personality disorders examinations (PDE): a preliminary report. J Pers Dis 1987; 1: 1–13
   Google Scholar
• Spitzer RL, Williams JBW, Gibbon M. Structured clinical interview for DSM-III-R personality disorders (SCID-II). New York State Psychiatric Institute, Biometrics Research, New York 1987
   Google Scholar
• Stangl D, Pfohl B, Simmerman M, Bowers W, Carenthal C. Structured interview for DSM-III personality disorders. Arch Gen Psychiatry 1985; 42: 591–596
   PubMed Web of Science ®Google Scholar
• Hyler SE, Rieder RO, Williams JBW, et al. The personality diagnostic questionnaire revised (PDQR). New York State Psychiatric Institute, Biometrics Research, New York 1987
   Google Scholar
• Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health diagnostic interview schedule: its history, characteristics and validity. Arch Gen Psychiatry 1981; 38: 382–389
   Web of Science ®Google Scholar
• Millon T. Millon multiaxial inventory manual3rd edn. National Computer Systems, Minneapolis 1983
   Google Scholar
• Millon T. Millon clinical multiaxial inventory manual supplement. National Computer Systems, Minneapolis 1984
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders3rd edn, revised. American Psychiatric Association, Washington 1987
   Google Scholar
• Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35: 773–782
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Endicott J, Robins E. Schedule for affective disorders and schizophrenia (SADS)3rd edn. New York State Psychiatric Institute, Biometrics Research, New York 1977
   Google Scholar
• Tyrer P, Alexander J. Classification of personality disorder. Br J Psychiatry 1979; 135: 163–167
   PubMed Web of Science ®Google Scholar
• Mann AH, Jenkins R, Cutting JC, Cowen PJ. The development and use of a standardized assessment of abnormal personality. Psychol Med 1981; 11: 839–847
   PubMed Web of Science ®Google Scholar
• Tyrer P, Alexander J, Ferguson B. Personality assessment schedule. Personality disorders: diagnosis, management and course, P Tyrer. Wright, London 1988; 140–167, In
   Google Scholar
• Tyrer P, Alexander M, Cicchetti D, Cohen M, Remington M. Reliability of a schedule for rating personality disorders. Br J Psychiatry 1979; 135: 168–174
   PubMed Web of Science ®Google Scholar
• Tyrer P, Strauss S, Cicchetti D. Temporal reliability of personality in psychiatric patients. Psychol Med 1983; 13: 393–398
   PubMed Web of Science ®Google Scholar
• Perry JC. Problems and considerations in the valid assessment of personality disorders. Am J Psychiatry 1992; 149: 1645–1653
   PubMed Web of Science ®Google Scholar
• Weissman MM, Myers JK, Harding PS. Psychiatric disorder in a US urban community. Am J Psychiatry 1978; 135: 459–462
   PubMed Web of Science ®Google Scholar
• Myers JK, Weissman MM, Tischler GL, et al. Six month prevalence of psychiatric disorders in three communities 1980–1982. Arch Gen Psychiatry 1984; 41: 959–967
   PubMed Web of Science ®Google Scholar
• Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984; 41: 949–958
   PubMed Web of Science ®Google Scholar
• Casey P, Gall J. The relationship between neurosis and personality disorder. Br J Psychiatry 1983; 142: 404–408
   PubMed Web of Science ®Google Scholar
• Kass F, Skodol AM, Charles E, et al. Scaled ratings of DSM-III personality disorders. Am J Psychiatry 1985; 142: 627–630
   PubMed Web of Science ®Google Scholar
• Morey L. Personality disorders in DSM-III and DSM-III-R: convergence, coverage and internal consistency. Am J Psychiatry 1988; 145: 573–577
   PubMed Web of Science ®Google Scholar
• Reich JH, Green AI. Effect of personality disorders on outcome of treatment. J Nerv Mental Dis 1991; 179: 74–82
   PubMed Web of Science ®Google Scholar
• Tyrer P, Seivewright N, Ferguson B, et al. The Nottingham Study of Neurotic Disorder: relationship between personality status and symptoms. Psychol Med 1990; 20: 423–431
   PubMed Web of Science ®Google Scholar
• Seivewright N. Relationship between life events and personality in psychiatric disorder. Stress Med 1987; 3: 163–168
   Google Scholar
• Rounsaville BJ, Weisman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982; 39: 161–166
   PubMed Web of Science ®Google Scholar
• Kosten TR, Rounsaville BJ, Kleber HD. DSM-III personality disorder in opiate addicts. Comp Psychiatry 1982; 23: 572–581
   PubMed Web of Science ®Google Scholar
• Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry 1985; 42: 1067–1071
   PubMed Web of Science ®Google Scholar
• Craig RJ. A psychometric study of the prevalence of DSM-III personality disorders among treated opiate addicts. Int J Addict 1988; 23: 115–124
   PubMed Web of Science ®Google Scholar
• Clerici M, Carta I, Cazzullo CL. Substance abuse and psychopathology. A diagnostic screening of Italian narcotic addicts. Soc Psychiatry Psychiatric Epidemiol 1989; 24: 219–226
   PubMed Web of Science ®Google Scholar
• Brooner RK, Schmidt CW, Felch LJ, Bigelow GE. Antisocial behaviour of intravenous drug abusers: implications for diagnosis of antisocial personality disorder. Am J Psychiatry 1992; 149: 482–487
   PubMed Web of Science ®Google Scholar
• Gill K, Nolimal D, Crowley TJ. Antisocial personality disorder, HIV risk behaviour and retention in methadone maintenance therapy. Drug Alcohol Depend 1992; 30: 247–252
   PubMed Web of Science ®Google Scholar
• DeJong CAJ, van den Brink W, Harteveld FM, van der Wielen EGM. Personality disorders in alcoholics and drug addicts. Comp Psychiatry 1993; 34: 87–94
   PubMed Web of Science ®Google Scholar
• Darke S, Hall W, Swift W. Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. Drug Alcohol Depend 1994; 34: 253–257
   PubMed Web of Science ®Google Scholar
• Rousar E, Brooner RK, Regier MW, Bigelow GE. Psychiatric distress in antisocial drug abusers: relation to other personality disorders. Drug Alcohol Depend 1994; 34: 149–154
   PubMed Web of Science ®Google Scholar
• Vukov M, Baba-Milkic N, Lecic D, Mijalkovic S, Marinkovic J. Personality dimensions of opiate addicts. Acta Psychiatr Scand 1995; 91: 103–107
   PubMed Web of Science ®Google Scholar
• Verheul R, van den Brink W, Hartgers C. Prevalence of personality disorders among alcoholics and drug addicts: an overview. Eur Addict Res 1995; 1: 166–177
   Google Scholar
• Malow RM, West JA, Williams JL, Sutker PB. Personality disorders classification and symptoms in cocaine and opioid addicts. J Consul Clin Psychol 1989; 57: 765–767
   PubMed Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. J Am Med Assoc 1990; 264: 2511–2518
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Coryell W. DSM-III personality disorder diagnoses in a non-patient sample: demographic correlates and comorbidity. Arch Gen Psychiatry 1989; 46: 682–689
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Kadden RM, Burleson JA, Babor TF, Apter A, Rounsaville BJ. Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?. Comp Psychiatry 1995; 36: 278–278
   PubMed Web of Science ®Google Scholar
• Bryant KJ, Rounsaville B, Spitzer RL, Williams JBW. Reliability of dual diagnosis: substance dependence and psychiatric disorders. J Nerv Mental Dis 1992; 180: 251–257
   PubMed Web of Science ®Google Scholar
• Griffin ML, Weiss RD, Mirin SM, Wilson H, Bouchard-Voelk B. The use of the diagnostic interview schedule in drug-dependent patients. Am J Drug Alcohol Abuse 1987; 13: 281–291
   PubMed Web of Science ®Google Scholar
• Dinwiddie SH, Reich T. Attribution of antisocial symptoms in coexistent antisocial personality disorder and substance abuse. Comp Psychiatry 1993; 34: 235–242
   PubMed Web of Science ®Google Scholar
• Farrell M, Ward J, Mattick R, et al. Methadone maintenance treatment in opiate dependence: a review. Br Med J 1994; 309: 997–1001
   PubMed Web of Science ®Google Scholar
• Kosten TA, Kosten TR, Rounsaville BJ. Personality disorders in opiate addicts show prognostic specificity. J Subst Abuse Treat, 6: 163–168
   PubMed Web of Science ®Google Scholar
• McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the addiction severity index. J Nerv Mental Dis 1990; 168: 26–33
   Google Scholar
• Brooner RK, Bigelow GE, Strain E, Schmidt CW. Intravenous drug abusers with antisocial personality disorder: increased HIV risk behaviour. Drug Alcohol Depend 1990; 26: 39–44
   PubMed Web of Science ®Google Scholar
• Brooner RK, Greenfield L, Schmidt C, Bigelow GE. Antisocial personality disorder and HIV infection among intravenous drug abusers. Am J Psychiatry 1993; 150: 53–58
   PubMed Web of Science ®Google Scholar
• Darke S, Hall W, Swift W. Geographical differences in risk-taking among Sydney methadone maintenance patients: a comparison of inner city and outer south western methadone maintenance patients. Drug Alcohol Rev 1994; 13: 301–305
   PubMedGoogle Scholar
• Treece C, Nicholson B. DSM-III personality type and dose levels in methadone maitnenance patients. J Nerv Mental Dis 1980; 168: 621–628
   PubMed Web of Science ®Google Scholar
• Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend 1994; 35: 31–35
   PubMed Web of Science ®Google Scholar
• Ravndal E, Vaglum P. Psychopathology and substance abuse as predictors of program completion in a therapeutic community for drug abusers: a prospective study. Acta Psychiat Scand 1991; 83: 217–222
   PubMed Web of Science ®Google Scholar
• Ravndal E, Vaglum P. Changes in antisocial aggressiveness during treatment in a heirarchical therapeutic community. A prospective study of personality changes. Acta Psychiat Scand 1991; 84: 524–530
   PubMed Web of Science ®Google Scholar
• Fals-Stewart W. Personality characteristics of substance abusers: an MCMI cluster typology of recreational drug users treated in therapeutic community and its relationship to length of stay and outcome. J Pers Assess 1992; 59: 515–527
   PubMed Web of Science ®Google Scholar
• Kay SR, Kalathara M, Meinzer AE. Diagnostic and behavioural characteristics of psychiatric patients who abuse substances. Hosp Commun Psychiatry 1989; 40: 1062–1069
   PubMedGoogle Scholar
• Toner BB, Gillies LA, Prendergast P, Cote FH, Browne C. Substance use disorders in a sample of Canadian patients with chronic mental illness. Hosp Commun Psychiatry 1992; 43: 251–254
   PubMedGoogle Scholar
• Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in borderline personality disorder. Am J Psychiatry 1990; 147: 1002–1007
   PubMed Web of Science ®Google Scholar
• Miller FT, Abrahams T, Dulit R, Fyer M. Substance abuse in borderline personality disorder. Am J Drug Alcohol Abuse 1993; 19: 491–497
   PubMed Web of Science ®Google Scholar
• Sanguineti VR, Samuel SE. Co-morbid substance abuse and recovery from acute psychiatric relapse. Hosp Commun Psychiatry 1993; 44: 1073–1076
   PubMedGoogle Scholar
• Dinwiddie SH, Reich T, Cloninger CR. Psychiatric co-morbidity and suicidality among intravenous drug users. J Clin Psychiatry 1992; 53: 364–369
   PubMed Web of Science ®Google Scholar
• Kernberg OD. Borderline conditions and pathological narcissism. Jason Aronson, New York 1975
   Google Scholar
• Dahl G, Mersky DM. Clinical patterns in a behaviour modification unit. Can J Psychiatry 1981; 26: 460–463
   PubMed Web of Science ®Google Scholar
• Novaco R. The cognitive regulation of anger and stress. Cognitive-behavioural interventions: theory research and procedures, P Kendall, S Hollon. Academic Press, New York 1979, In
   Google Scholar
• Parloff MB, Dies RR. Group psychotherapy outcome research 1966–1975. Int J Group Psychother 1977; 27: 281–319
   PubMed Web of Science ®Google Scholar
• Appleby L, Joseph P. Management of personality disorder. Int Rev Psychiatry 1991; 3: 59–70
   Google Scholar
• Tyrer P, Seivewright N. Pharmacological treatment of personality disorders. Clin Neuropharmacol 1988; 11: 493–499
   PubMed Web of Science ®Google Scholar
• Stein G. Drug treatment of the personality disorders. Br J Psychiatry 1992; 161: 167–184
   PubMed Web of Science ®Google Scholar
• Gitlin MJ. Pharmacotherapy of personality disorders: conceptual framework and clinical strategies. J Clin Psychopharmacol 1993; 13: 343–353
   PubMed Web of Science ®Google Scholar
• Norden MJ. Fluoxetine in borderline personality disorder: progress in neuropharmacology. Biol Psych 1989; 13: 885–893
   Web of Science ®Google Scholar
• Markowitz PJ, Calabrese JR, Schulz SC, Meltzer HY. Fluoxetine in the treatment of borderline and schizotypal personality disorder. Am J Psych 1991; 148: 1064–1067
   PubMed Web of Science ®Google Scholar
• Kavoussi RJ, Liu J, Caccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994; 55: 137–141
   PubMed Web of Science ®Google Scholar
• Amit Z, Smith R, Gill K. Serotonin uptake inhibitors: effects on motivated consummatory behaviours. J Clin Psychiatry 1991; 52: 55–60
   PubMed Web of Science ®Google Scholar
• Sellers EM, Higgins GA, Tomkins DM, Romach MK, Toneatto T. Opportunities for treatment of psychoactive substance use disorders with serotenergic medications. J Clin Psychiatry 1991; 52: 49–54, suppl
   PubMed Web of Science ®Google Scholar
• Cowdrey RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluperazeine and tranylcypromine. Arch Gen Psychiatry 1988; 454: 111–119
   Google Scholar
• Mos J, Olivier B. Pro-aggressive actions of benzodiazepines. Ethopharmacology of agonistic behaviour in animals and humans, Olivier B, Mos J, Brain PF. Martinus Nijhoff, Dordrecht 1987; 197–206, In
   Google Scholar
• Walker R. Substance abuse and B-cluster disorders I: understanding the dual diagnosis patient. J Psychoact Drugs 1992; 24: 223–232
   PubMed Web of Science ®Google Scholar
• Polson RG, Fleming PM, O'Shea JK. Fluoxetine in the treatment of amphetamine dependence. Hum Psychopharmacol 1993; 8: 55–58
   Web of Science ®Google Scholar
• Pollack MH, Rosenbaum JF. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry 1991; 52: 31–33
   PubMed Web of Science ®Google Scholar
• Gerra G, Marcato A, Caccavari R, et al. Clonidine and opiate receptor antagonists in the treatment of heroin addiction. J Subst Abuse Treat 1995; 12: 35–41
   PubMed Web of Science ®Google Scholar